Donald McDonnell, PhD, Glaxo-Wellcome Professor of MCB and Chairman, Department of Pharmacology and Cancer Biology at Duke Cancer Institute, describes his research on a particular type of cholesterol that links obesity and breast cancer.
Lori Elliot, Raleigh, North Carolina, was diagnosed with breast cancer in June 2004. She received advanced care at Duke Cancer Center. Here, she shares her inspirational journey back to health and wellness. Duke Cancer Institute -- A ground-breaking model for patient care is fostered here. Learn more at www.dukehealth.org. #criticalmassoftalent #movingfurtherfaster #agroundbreakingmodel4care
Many thanks to filmmakers Will Anderson and David Gwynn.
Can you imagine being a healthy triathlete one day and being told you’d lose your leg to cancer the next? That’s what happened to Peter Morrissette when he was diagnosed with sarcoma, a soft tissue cancer. Thankfully, his doctor sent him to Duke Cancer Institute.
Land your CRUSHing blow to colorectal cancer by stepping out with cancer survivor Erin Wood and Dr. Hurwitz on Saturday, March 19, for the 2016 CRUSH Colorectal Cancer 5K & Family Fun Walk. The run and the walk begin and finish on Ninth Street in Durham. For more information or to register, visit dukeCRC.org.
Steve Patierno, PhD, Deputy Director with Duke Cancer Institute, talks about community outreach focused on prevention and early detection. Should you or a loved one be diagnosed with cancer, we work to remove the barriers to Duke quality cancer care. For more information, visit the DCI Office of Health Equity and Disparity at http://www.dukecancerdisparities.org.
People with gynecologic and prostate cancers can now receive high-dose, targeted radiation therapy in a few hours in a dedicated brachytherapy suit at the Duke Cancer Center. Having advanced imaging and treatment planning technology in one convenient location minimizes the need for an overnight hospital stay, as well as the discomfort and safety concerns typically associated with delivering high-dose radiation. For more info: http://bit.ly/1yPhkHt
The Department of Pathology and Laboratory Medicine, in conjunction with the Abramson Cancer Center, is at the leading edge of personalized medicine with its Center for Personalized Diagnostics and the Clinical Cell and Vaccine Production Facility. To learn more about the Center for Personalized Diagnostics, visit http://www.pennmedicine.org/personalized-diagnostics/.
Penn Medicine's Department of Pathology and Laboratory Medicine is at the forefront of shaping the future of personalized medicine and, in conjunction with the Abramson Cancer Center, is developing a Center for Personalized Diagnostics, integrating molecular pathology, pathology informatics, and genomic pathology for diagnosis and research. The Department also maintains the Clinical Cell and Vaccine Production Facility as an ACC Shared Resource.
A key component in personalized medicine is diagnostics: the ability to identify molecular signatures present, for example, in the DNA of tumor cells. Collection of a large number of molecular